Halozyme Therapeutics Inc (HALO)
44.32
+0.97
(+2.24%)
USD |
NASDAQ |
May 31, 16:00
44.32
0.00 (0.00%)
Pre-Market: 20:00
Halozyme Therapeutics Total Long Term Debt (Quarterly): 1.501B for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.501B |
December 31, 2023 | 1.499B |
September 30, 2023 | 1.498B |
June 30, 2023 | 1.496B |
March 31, 2023 | 1.494B |
December 31, 2022 | 1.506B |
September 30, 2022 | 1.504B |
June 30, 2022 | 1.246B |
March 31, 2022 | 877.64M |
December 31, 2021 | 876.67M |
September 30, 2021 | 875.70M |
June 30, 2021 | 874.74M |
March 31, 2021 | 873.77M |
December 31, 2020 | 397.23M |
September 30, 2020 | 393.63M |
June 30, 2020 | 390.08M |
March 31, 2020 | 389.43M |
December 31, 2019 | 402.59M |
September 30, 2019 | 63.84M |
June 30, 2019 | 84.96M |
March 31, 2019 | 105.40M |
December 31, 2018 | 126.38M |
September 30, 2018 | 146.46M |
June 30, 2018 | 166.04M |
March 31, 2018 | 185.16M |
Date | Value |
---|---|
December 31, 2017 | 202.35M |
September 30, 2017 | 206.85M |
June 30, 2017 | 211.03M |
March 31, 2017 | 214.03M |
December 31, 2016 | 216.62M |
September 30, 2016 | 212.20M |
June 30, 2016 | 208.14M |
March 31, 2016 | 196.02M |
December 31, 2015 | 49.83M |
September 30, 2015 | 49.79M |
June 30, 2015 | 49.75M |
March 31, 2015 | 49.72M |
December 31, 2014 | 49.86M |
September 30, 2014 | 49.84M |
June 30, 2014 | 49.82M |
March 31, 2014 | 49.79M |
December 31, 2013 | 49.77M |
September 30, 2013 | 29.75M |
June 30, 2013 | 29.72M |
March 31, 2013 | 29.69M |
December 31, 2012 | 29.66M |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
63.84M
Minimum
Sep 2019
1.506B
Maximum
Dec 2022
912.26M
Average
876.19M
Median
Total Long Term Debt (Quarterly) Benchmarks
Novavax Inc | 168.43M |
Denali Therapeutics Inc | -- |
AIM ImmunoTech Inc | 2.573M |
Protalix BioTherapeutics Inc | 20.42M |
Armata Pharmaceuticals Inc | -- |